Intermediate compounds and processes for the preparation of tapentadol and related compounds

Details for Australian Patent Application No. 2010337825 (hide)

Owner MAPI PHARMA LIMITED

Inventors Marom, Ehud; Mizhiritskii, Michael

Agent Pipers

Pub. Number AU-A-2010337825

PCT Pub. Number WO2011/080736

Priority 61/290,532 29.12.09 US

Filing date 26 December 2010

Wipo publication date 7 July 2011

International Classifications

A01N 33/02 Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds

A61K 31/135 - having aromatic rings, e.g. methadone

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/080736 Priority application(s): WO2011/080736

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010337829-Methods for enhancing natural killer cell proliferation and activity

2010337822-Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof